EUVIMEDEUVIMED entdecken
Crossref

MiR-223-3p Promotes Osteoporosis Progression by Repressing Osteogenic Differentiation via Targeting FHL1/Wnt/β-catenin Signaling

Kairi Shi, Junyu Wei, Jianming Chen

Cell Biochemistry and Biophysics · 2024

DOI: 10.1007/s12013-024-01579-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Kairi Shi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Ningbo No.6 Hospital, Ningbo, Zhejiang, 315040, China. Hauptthemen laut MEDLINE: MicroRNAs, Osteogenesis, Cell Differentiation, Wnt Signaling Pathway. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this research was to unveil the potential along with potential mechanism of miR-223-3p in osteoporosis. RT-qPCR together with western blot was implemented to examine miR-223-3p, FHL1, along with osteogenic markers levels during bone marrow mesenchymal stem cells (BMSCs) differentiation. The ALP activity staining along with alizarin red staining (ARS) were implemented to assess ALP activity as well as the mineralization ability of BMSCs. Binding sequences for miR-223-3p and FHL1 from starBase website were validated through dual-luciferase reporter gene assay. MiR-223-3p was down-regulated in BMSCs during osteoblasts differentiation, and miR-223-3p elevation hindered BMSCs' osteogenic differentiation. FHL1 belonged to the target mRNA of miR-223-3p. FHL1 presented up-regulation in BMSCs during osteoblasts differentiation. More importantly, FHL1 expression was negative modulated by miR-223-3p in BMSCs during osteoblasts differentiation, and FHL1 elevation could inverse the inhibited BMSCs' osteogenic differentiation modulated by miR-223-3p elevation. Furthermore, miR-223-3p elevation repressed the Wnt/β-catenin pathway activity in lithium chloride-treated BMSCs, and FHL1 overexpression counteracted the inhibitory effect of the Wnt/β-catenin pathway caused by miR-223-3p up-regulation. Collectively, miR-223-3p accelerates osteoporosis progression by repressing osteogenic differentiation through targeting FHL1/Wnt/β-catenin signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsOsteogenesisCell DifferentiationWnt Signaling PathwayOsteoporosisLIM Domain ProteinsMuscle ProteinsIntracellular Signaling Peptides and ProteinsMesenchymal Stem CellsHumansAnimalsOsteoblastsCells, CulturedDisease Progressionbeta Catenin

Stichwörter der Autor:innen

Bone marrow mesenchymal stem cellsFHL1MiR-223-3pOsteogenic differentiationOsteoporosisWnt/β-catenin

Substanzen

MicroRNAsLIM Domain ProteinsMuscle ProteinsIntracellular Signaling Peptides and Proteinsbeta CateninFHL1 protein, humanMIR223, human

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Ningbo No.6 Hospital, Ningbo, Zhejiang, 315040, China.
  • Department of Orthopedic Surgery, Ningbo No.6 Hospital, Ningbo, Zhejiang, 315040, China. chenjianmingnb6@163.com.

Förderung

  • Natural Science Foundation of Hebei Province

Zitieren

APA

Shi, K., Wei, J., & Chen, J. (2024). MiR-223-3p Promotes Osteoporosis Progression by Repressing Osteogenic Differentiation via Targeting FHL1/Wnt/β-catenin Signaling. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01579-0

Vancouver

Shi K, Wei J, Chen J. MiR-223-3p Promotes Osteoporosis Progression by Repressing Osteogenic Differentiation via Targeting FHL1/Wnt/β-catenin Signaling. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01579-0

BibTeX
@article{Shi2024,
  author = {Shi, Kairi and Wei, Junyu and Chen, Jianming},
  title = {MiR-223-3p Promotes Osteoporosis Progression by Repressing Osteogenic Differentiation via Targeting FHL1/Wnt/β-catenin Signaling},
  journal = {Cell Biochemistry and Biophysics},
  year = {2024},
  doi = {10.1007/s12013-024-01579-0}
}
Kostenlos starten →